P-061 - PHARMACOKINETICS AND PHARMACODYNAMICS OF CASIRIVIMAB AND IMDEVIMAB IN OUTPATIENTS WITH COVID-19.

S. Ganguly¹, K. Turner¹, J. Davis¹, H. Hassan¹, S. Irvin¹, M. Partridge¹, J. Nguyen¹, K. Lin¹, T. Norton¹, S. Ali¹, A. Hooper¹, N. Al-Huniti¹, H. Yan¹, A. Ballesteros-Perez², A. DiCioccio¹; ¹Regeneron Pharmaceuticals, Inc., Tarrytown, NY, USA; ²Certara, Princeton, NJ, USA.